Balchem Co. (BCPC) Shares Bought by Legal & General Group Plc

Legal & General Group Plc increased its stake in shares of Balchem Co. (NASDAQ:BCPC) by 1.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 66,948 shares of the basic materials company’s stock after buying an additional 1,250 shares during the quarter. Legal & General Group Plc owned about 0.21% of Balchem worth $5,462,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC grew its holdings in shares of Balchem by 38.9% during the first quarter. Barclays PLC now owns 9,784 shares of the basic materials company’s stock valued at $799,000 after buying an additional 2,742 shares during the last quarter. The Manufacturers Life Insurance Company grew its holdings in shares of Balchem by 0.9% during the first quarter. The Manufacturers Life Insurance Company now owns 72,795 shares of the basic materials company’s stock valued at $5,951,000 after buying an additional 640 shares during the last quarter. MetLife Investment Advisors LLC grew its holdings in shares of Balchem by 82.6% during the first quarter. MetLife Investment Advisors LLC now owns 27,092 shares of the basic materials company’s stock valued at $2,215,000 after buying an additional 12,252 shares during the last quarter. UBS Group AG grew its holdings in shares of Balchem by 64.3% during the first quarter. UBS Group AG now owns 12,393 shares of the basic materials company’s stock valued at $1,013,000 after buying an additional 4,850 shares during the last quarter. Finally, Mason Street Advisors LLC grew its holdings in shares of Balchem by 6.8% during the first quarter. Mason Street Advisors LLC now owns 8,887 shares of the basic materials company’s stock valued at $727,000 after buying an additional 563 shares during the last quarter. 87.25% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ:BCPC opened at $99.37 on Thursday. Balchem Co. has a one year low of $70.23 and a one year high of $104.59. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.48 and a current ratio of 2.16. The firm has a market capitalization of $3.33 billion, a price-to-earnings ratio of 38.27 and a beta of 0.90.

Balchem (NASDAQ:BCPC) last posted its quarterly earnings results on Friday, May 4th. The basic materials company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.70 by $0.06. Balchem had a net margin of 15.18% and a return on equity of 14.50%. The company had revenue of $161.41 million for the quarter.

A number of brokerages have recently weighed in on BCPC. Vertical Group lowered shares of Balchem from a “buy” rating to a “hold” rating in a report on Monday, May 7th. They noted that the move was a valuation call. BidaskClub lowered shares of Balchem from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 12th. Finally, Pivotal Research raised shares of Balchem from a “sell” rating to a “hold” rating and set a $85.00 price objective on the stock in a report on Monday, May 7th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPC).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply